Zol treatment not only increased HCC cell susceptibility to T cell killing but also triggered T cell proliferation and induced cytokine production (IL-4, IL-5, IL-13, IFN-γ, GM-CSF, TNF-α) and grandzyme B [78]. This evidence concerns the gene IFNG and hepatocellular carcinoma.